AdvaMed down to business under Ubl
This article was originally published in Clinica
This was AdvaMed president Stephen Ubl's first annual meeting since taking the helm in July, and already measured tone and passion for policy, and emphasis on transparency is already pervading the organisation, writes Karen Riley. A year ago, the meeting emphasised entertainment over substance. Not so in Naples, where the after-luncheon speakers were a Senator and a deputy secretary of Health and Human Services - quite a contrast from last year's inspirational speech by a renowned mountain climber who beat cancer.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.